[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 2, Issue 4 (winter 2025) ::
Health Res Develop 2025, 2(4): 60-70 Back to browse issues page
Treatment Satisfaction with Medicines in patients with multiple sclerosis and factors related in Sabzevar
Ali Khatib1 , Maasoumeh Barkhordari-Sharifabad *2
1- Neyshabur University of Medical Sciences, khatiba1@nums.ac.ir
2- Yazd Branch, Islamic Azad University, barkhordary_m@yahoo.com , barkhordary_m@yahoo.com
Abstract:   (182 Views)
Background & Aims: Multiple sclerosis, as the most common demyelinating disease of the central nervous system, requires continuous Adherence to Treatment due to its chronic nature. Therefore, according to the importance of Treatment Satisfaction with Medicines in Adherence to Treatment, the present study was conducted with the aim of determining the level of satisfaction with drug treatment and its related factors in patients suffering from this disease in Sabzevar.
Materials & Methods: This cross-sectional descriptive study was conducted on 44 MS patients who referred to treatment centers and Sabzevar MS Association from October 2022 to March 2023, using an easy and accessible non-probability sampling method. The data collection tool included demographic information questionnaire and Treatment Satisfaction with Medicines questionnaire (SATMED-Q). Data was analyzed by SPSS-23, using descriptive and inferential statistics such as one-way analysis of variance statistical and Pearson correlation coefficients.
Results: The average age of the patients was 38.9 years and most of the patients were female (70.5%). In this study, the mean score of Treatment Satisfaction with Medicines in patients was 59.54±13.61. Among the dimensions of satisfaction, the highest mean score was related to the dimension of global satisfaction and the lowest mean was related to the dimension of side effects. Education, age and patient history showed significant relationships with patients satisfaction (P<0.05).
Conclusion: Patient satisfaction is an important factor in disease control and recovery. According to the findings of this research, in comparison with other countries, Treatment Satisfaction with Medicines in multiple sclerosis patients was not reported at a favorable level in terms of side effects of drugs, which requires investigation and follow-up by health decision makers.
Keywords: multiple sclerosis, satisfaction with treatment, SATMED-Q questionnaire ​​​​​​​
Full-Text [PDF 1110 kb]   (59 Downloads)    
Type of Study: Original | Subject: Special
Received: 2024/03/20 | Accepted: 2025/02/19 | Published: 2025/02/28
References
1. Heidari Sureshjani S, Eslami A A, Hassanzadeh A. The Quality of Life among Multiple Sclerosis Patients in Isfahan, Iran. HSR 2012; 7 (5).
2. McGuinness SD, Peters S. The diagnosis of multiple sclerosis: Peplau's Interpersonal Relations Model in practice. Rehabil Nurs 1999; 24(1): 30-3. [DOI:10.1002/j.2048-7940.1999.tb01828.x] [PMID]
3. Etemadifar M, Ashtari F-. Diagnosis and Treatment of Multiple sclerosis (MS). Isfahan: Four garden Publication; 2002. p. 1-10, 60-1.
4. Alfredsson L, Olsson T. Lifestyle and Environmental Factors in Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine 2019; 9(4):A028944. [DOI:10.1101/cshperspect.a028944] [PMID] []
5. Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Multiple Sclerosis Journal. 2020;26(14):1816 -21. [DOI:10.1177/1352458520970841] [PMID] []
6. Karimi S, Andayeshgar B, Khatony A. Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study. BMC psychiatry. 2020;20(1):1-8. [DOI:10.1186/s12888-020-02579-z] [PMID] []
7. Foroughipour, M., Etemadi, M., Nikkhah, K., Afzalnia, A., Hazrati, N., Ebadi, F., Farzadfard, M. Assessment of disability (EDSS) and liver complications in multiple sclerosis patients treated by Recigen in comparison with Betaferon.. medical journal of mashhad university of medical sciences, 2014; 57(5): 669-675.
8. Turner, A. P., Williams, R. M., Sloan, A. P., & Haselkorn, J. K. (2009). Injection anxiety remains a long-term barrier to medication adherence in multiple sclerosis. Rehabilitation Psychology, 54(1), 116-121. [DOI:10.1037/a0014460] [PMID]
9. Mohr DC, Goodkin DE, Masuoka L, et al. Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis. Multiple Sclerosis Journal. 1999;5(3):192-197. https://doi.org/10.1177/135245859900500309 [DOI:10.1191/135245899678846069] [PMID]
10. Fraser C, Hadjimichael O, Vollmer T. Predictors of adher ence to glatiramer acetate therapy in individuals with self-reported progressive forms of multiple sclerosis. Journal of Neuroscience Nursing, 2003:35(2): 163-174. [DOI:10.1097/01376517-200306000-00006] [PMID]
11. Frank Petrak, Elmar Stridde, Friedhelm Leverkus, Alexander A. Crispin, Thomas Forst, Andreas Pfützner; Development and Validation of a New Measure to Evaluate Psychological Resistance to Insulin Treatment. Diabetes Care 1 September 2007; 30 (9): 2199-2204. [DOI:10.2337/dc06-2042] [PMID]
12. Pérez Unanua MP, Alonso Fernández M, López Simarro F, Soriano Llora T, Peral Martínez I, Mancera Romero J, et al. [Adherence to healthy lifestyle behaviours in patients with type 2 diabetes in Spain]. Semergen. 2020;S1138-3593(20):30317- 30318.
13. Bennich BB, Munch L, Overgaard D, Konradsen H, Knop FK, Røder M, et al. Experience of family function, family involvement, and self-management in adult patients with type 2 diabetes: A thematic analysis. J Adv Nurs. 2020;76(2):621-631. [DOI:10.1111/jan.14256] [PMID]
14. Bahrami M, Dehghani S, Eghbali M, Beigi RD. The effect of a communicative-educative program on patients’ satisfaction from pain management following cancer surgery. Medical Ethics Journal. 2014;8(26):47-67.
15. Esfahani P, Nezamdust F. Patients' Satisfaction in Hospitals of Iran: A systematic Review and Meta-Analysis. Qom Univ Med Sci J 2019; 13 (4) :58-72. [DOI:10.29252/qums.13.4.58]
16. Toljamo M, Hentinen M. Adherence to self‐care and social support. Journal of clinical nursing. 2001;10(5):618-27. [DOI:10.1046/j.1365-2702.2001.00520.x] [PMID]
17. Williams B. Patient satisfaction: a valid concept? SocSci Med 1994;38:509-16. [DOI:10.1016/0277-9536(94)90247-X] [PMID]
18. Ruiz MA, Pardo A, Rejas J, Soto J, Villasante F, Aranguren JL. Development and Validation of the "Treatment Satisfaction with Medicines Questionnaire"(SATMED‐Q)©. Value in Health. 2008;11(5):913-26. [DOI:10.1111/j.1524-4733.2008.00323.x] [PMID]
19. Soleimanpour H, Gholipouri C, Salarilak S, Raoufi P, Vahidi RG, Rouhi AJ, et al. Emergency department patient satisfaction survey in Imam Reza hospital, Tabriz, Iran. International Journal of Emergency Medicine 2011; 4:2. [DOI:10.1186/1865-1380-4-2] [PMID] []
20. Lai VKW, Lee A, Leung P, Chiu CH, Ho KM, Gomersall CD, et al. Patient and family satisfaction levels in the intensive care unit after elective cardiac surgery: study protocol for a randomised controlled trial of a preoperative patient education intervention. BMJ Open. 2016;6(6):1-6. [DOI:10.1136/bmjopen-2016-011341] [PMID] []
21. Goldenberg MM. Multiple sclerosis review. P T. 2012 Mar;37(3):175-84.
22. Hosseinzadeh A, Baneshi MR, Sedighi B, Kermanchi J, Haghdoost AA. Incidence of Multiple Sclerosis in Iran: A Nationwide, Population-Based Study. Public Health 2019; 175:138-44. [DOI:10.1016/j.puhe.2019.07.013] [PMID]
23. Rezaali S, Khalilnezhad A, Moghadasi AN, Chaibakhsh S, Sahraian MA. Epidemiology of Multiple Sclerosis in Qom: Demographic Study in Iran. Iranian J Neurology 2013;12(4):136.
24. Eskandarieh S, Heydarpour P, Elhami SR, Sahraian MA. Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran. Iranian J Public Health 2017; 46(5): 699.
25. Manchon, E.; Laplaud, D.; Vukusic, S.; Labauge, P.; Bensa, C.; Kobelt, G.; Lotz, M.; Lebrun-Frenay, C.European Journal of Neurology ; 28(SUPPL 1):283, 2021.
26. Sharmin, S., Lefort, M., Andersen, J.B. et al. Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts. CNS Drugs 35, 1217-1232 (2021). [DOI:10.1007/s40263-021-00860-7] [PMID]
27. Hosseininezhad M, Saadat S, Bakhshipour H, Nasiri P. Prevalence and Incidence of Multiple Sclerosis (MS) in Guilan Province. JSSU 2021; 29 (1) :3438-3447. [DOI:10.18502/ssu.v29i1.5887]
28. Dardiotis E, Perpati G, Borsos M, Nikolaidis I, Tzanetakos D, Deretzi G, et al. Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece. Neurology and Therapy. 2022;11(3):1375-90. [DOI:10.1007/s40120-022-00384-2] [PMID] []
29. Turčáni P, Mašková J, Húska J. Real-world treatment patterns of disease modifying therapy (dmt) for patients with relapse-remitting multiple sclerosis and patient satisfaction with therapy: results of the non-interventional SKARLET study in Slovakia. Patient preference and adherence. 2020:1129-35. [DOI:10.2147/PPA.S254427] [PMID] []
30. Hao J, Pitcavage J, Jones J, Hoegerl C, Graham J. Measuring adherence and outcomes in the treatment of patients with multiple sclerosis. Journal of Osteopathic Medicine. 2017;117(12):737-47. [DOI:10.7556/jaoa.2017.145] [PMID]
31. Vermersch P, Hobart J, Dive-Pouletty C, Bozzi S, Hass S, Coyle PK. Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose? Multiple Sclerosis Journal. 2017;23(4):604-13. [DOI:10.1177/1352458516657441] [PMID] []
32. Rouhafza M, Adhami Moghadam F, Sahebalzamani M. Assessment the relationship between patient satisfaction and quality of hospital services based on SERVQUAL Model in the hospitals related to Islamic Azad University, Tehran Medical Sciences Branch in 2015. Medical Sciences 2016; 26: 173-1791.
33. Miseviciene I, Milasauskiene Z. Patient satisfaction with the work of the hospital medical personnel. Medicina 2002; 38:559
34. González-Valentín A, Padín-López S, de RamónGarrido E. Patient satisfaction with nursing care in a regional university hospital in southern Spain. Journal of Nursing Care Quality 2005; 20:63- 72. [DOI:10.1097/00001786-200501000-00011] [PMID]
35. Davari A, Daneshkazemi A R, Amirzadeiranagh M H, Masoumi S M R. Evaluation of Patient's Satisfaction on Dental Health Services in Dental School and Specialized Education Clinics Affiliated to Shahid Sadoughi University of Medical Sciences in Yazd in 2017-2018. JSSU 2021; 29 (4) :3681-3692. [DOI:10.18502/ssu.v29i4.6500]
36. mahmoodian, F., jahromi, N., nabeiei, P. Investigation of Satisfaction Level of Outpatients Referring to Psychiatry Clinics with Observation of Professional Ethics Principles by the Psychiatric Team of Shiraz University of Medical Sciences. Sadra Medical Journal, 2014; 2(3): 279-288.
37. Heidari A, Seyyedi M. The level of patients' satisfaction about general physicians of Qom and effective factors of it. Journal of medical organization of Islamic Republic of Iran 2008; 26(4): 530-540.
38. Saifrabie M.A, Shahidzadeh Mahani A.. Patient satisfaction: a study of Hamedan teaching and general hospitals. Payesh 2006; 5 (4).
39. Sadjadian A.S, Kaviani A, Yunesian M, Fateh A. Satisfaction with breast clinical care . Payesh 2002; 1 (3) :55-63.
40. Khezri L, Ravanipour M, Jahanpour F, Mirzaee K. Assessment of patient satisfaction with nursing services provided in general wards of university hospitals in Bushehr 2012 Nursing Journal of the Vulnerable 2015; 2: 36-46.
41. Farahani MF, Shamsikhani S, Hezaveh MS. Patient satisfaction with nursing and medical care in hospitals affiliated to arak university of medical sciences in 2009. Nursing and midwifery studies 2014; 3: e14022. [DOI:10.17795/nmsjournal14022] [PMID] []
42.  
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Ethics code: IR.IAU.KHUISF.REC.1401.165



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khatib A, Barkhordari-Sharifabad M. (2025). Treatment Satisfaction with Medicines in patients with multiple sclerosis and factors related in Sabzevar. Health Res Develop. 2(4), 60-70. doi:10.61186/jhrd.2.4.60
URL: http://jhrd.trjums.ac.ir/article-1-54-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 2, Issue 4 (winter 2025) Back to browse issues page
پژوهش و توسعه سلامت Health research and development
Persian site map - English site map - Created in 0.06 seconds with 37 queries by YEKTAWEB 4710